Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Hemostasis01:05

Introduction to Hemostasis

6.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.0K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

5.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

625
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
625
Disorders of Hemostasis01:24

Disorders of Hemostasis

726
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
726
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

4.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.8K
Coagulation01:09

Coagulation

5.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coupled Electronic and Ionic Conductivity in Strain-Stiffening Hydrogels.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Strain stiffening and compression-induced softening of composite fibrous hydrogels derived from rod-shaped nanoparticles and a synthetic copolymer.

Materials horizons·2026
Same author

Advanced polyelectrolyte complexes for ultrafast hemostasis and blood superabsorption.

Acta biomaterialia·2025
Same author

Controlling Enzymatic Degradation of Carboxyl-Modified Chitosan and Hyaluronic Acid Biopolymers Using Dynamic Covalent Cross-Linking.

ACS applied bio materials·2025
Same author

Nanocolloidal hydrogel mimics the structure and nonlinear mechanical properties of biological fibrous networks.

Proceedings of the National Academy of Sciences of the United States of America·2023
Same author

Colloidal Clusters and Networks Formed by Oppositely Charged Nanoparticles with Varying Stiffnesses.

ACS nano·2023

Related Experiment Video

Updated: Jun 9, 2025

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

793

External Bleeding and Advanced Biomacromolecules for Hemostasis.

Sajjad Fanaee1, William Austin1, Mark Filiaggi1,2

  • 1School of Biomedical Engineering, Dalhousie University, Halifax, NS B3H 4R2, Canada.

Biomacromolecules
|October 28, 2024
PubMed
Summary

This review explores advanced hemostatic materials designed to improve blood clot formation and control bleeding. These innovative biomaterials offer potential for better outcomes in clinical and emergency situations.

More Related Videos

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
08:27

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine

Published on: December 6, 2024

235
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

13.7K

Related Experiment Videos

Last Updated: Jun 9, 2025

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

793
A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
08:27

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine

Published on: December 6, 2024

235
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

13.7K

Area of Science:

  • Biomaterials Science
  • Hemostasis Research
  • Medical Device Development

Background:

  • Hemorrhage presents a significant clinical challenge, prompting extensive research into hemostasis.
  • The human body employs complex mechanisms for blood clot formation and hemostasis.
  • Biomaterials are being developed to enhance the body's natural bleeding control response.

Purpose of the Study:

  • To review the mechanisms of hemostasis and bleeding.
  • To examine in vitro and in vivo models for studying hemostatic materials.
  • To provide a comprehensive overview of current and emerging hemostatic technologies.

Main Methods:

  • Literature review of hemostasis mechanisms.
  • Analysis of bleeding models and techniques.
  • Categorization of hemostatic materials based on function (absorbent, adhesive, pro-coagulant).

Main Results:

  • Detailed examination of diverse hemostatic materials, including absorbent, wet adhesive, and pro-coagulant types.
  • Overview of materials in market, preclinical testing, and research phases.
  • Identification of advancements in hemostatic technology.

Conclusions:

  • Emerging hemostatic materials show significant promise for improving bleeding control.
  • These advancements have the potential to enhance patient care in clinical and emergency settings.
  • Continued research in hemostatic biomaterials is crucial for addressing bleeding complications.